Prognostic significance of platelet–lymphocyte ratio in patients receiving first-line tyrosine kinase inhibitors for metastatic renal cell cancer
Crossref DOI link: https://doi.org/10.1186/s40064-016-3592-4
Published Online: 2016-10-28
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Park, Tae Ju
Cho, Yang Hyun
Chung, Ho Seok
Hwang, Eu Chang https://orcid.org/0000-0002-2031-124X
Jung, Sung-Hoon
Hwang, Jun Eul
Bae, Woo Kyun
Kim, Jin Woong
Heo, Suk Hee
Hur, Young Hoe
Jung, Seung Il
Kwon, Dong Deuk
License valid from 2016-10-28